Half-life extension strategies (e.g., albumin or Fc-binding concepts in related molecules) inform sampling cadence for IG levels, satiety peptides, and hepatic flux markers
22,53 In the LEADER trial, which enrolled 9,340 patients with T2D at high cardiovascular risk, liraglutide demonstrated modest reduction in systolic BP (mean difference: 1.2 mm Hg
Additionally, patients using both treatments may attribute weight loss or adverse effects to the wrong agent, complicating clinical assessment
Dual GLP- 1 Receptor AgonistsCagriSema A long-acting amylin analog called cagrilintide is being developed in conjunction with semaglutide 2.4 mg (CagriSema) to treat T2DM [101]
Who is eligible for semaglutide
Schedule a visit with Passion Health Advanced Primary Care to discuss safe, FDA-approved weight-management options